Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR gamma | 6 | 2017 | 55 | 1.650 |
Why?
|
| Acrolein | 5 | 2017 | 17 | 1.600 |
Why?
|
| Environmental Pollutants | 3 | 2013 | 198 | 0.860 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 61 | 0.790 |
Why?
|
| Signal Transduction | 5 | 2020 | 2111 | 0.780 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2019 | 142 | 0.710 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 44 | 0.650 |
Why?
|
| Inflammation | 2 | 2017 | 729 | 0.620 |
Why?
|
| Blood Pressure | 5 | 2014 | 658 | 0.590 |
Why?
|
| Vasoconstriction | 5 | 2014 | 40 | 0.580 |
Why?
|
| Nitric Oxide | 7 | 2014 | 381 | 0.550 |
Why?
|
| Oxidative Stress | 4 | 2013 | 990 | 0.520 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 70 | 0.510 |
Why?
|
| Hypertension | 4 | 2014 | 817 | 0.500 |
Why?
|
| Aorta | 4 | 2014 | 197 | 0.470 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2019 | 92 | 0.440 |
Why?
|
| Clofibrate | 2 | 2014 | 12 | 0.440 |
Why?
|
| NF-kappa B | 2 | 2013 | 355 | 0.410 |
Why?
|
| PPAR alpha | 1 | 2014 | 43 | 0.410 |
Why?
|
| Serum Response Factor | 1 | 2013 | 10 | 0.390 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 221 | 0.380 |
Why?
|
| Antihypertensive Agents | 3 | 2014 | 285 | 0.380 |
Why?
|
| Thiazolidinediones | 3 | 2014 | 49 | 0.370 |
Why?
|
| Kidney | 5 | 2010 | 363 | 0.350 |
Why?
|
| Animals | 19 | 2020 | 16694 | 0.340 |
Why?
|
| Neoplasms | 1 | 2020 | 1341 | 0.310 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2009 | 6 | 0.310 |
Why?
|
| Thromboxane A2 | 3 | 2010 | 20 | 0.300 |
Why?
|
| Angiotensin II | 3 | 2010 | 103 | 0.280 |
Why?
|
| Dinoprost | 3 | 2014 | 22 | 0.280 |
Why?
|
| Mice, Knockout | 3 | 2017 | 1010 | 0.270 |
Why?
|
| Rats | 13 | 2019 | 3701 | 0.260 |
Why?
|
| Kidney Glomerulus | 1 | 2007 | 85 | 0.250 |
Why?
|
| Mice | 4 | 2020 | 6490 | 0.230 |
Why?
|
| Vascular Diseases | 1 | 2005 | 33 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2014 | 1737 | 0.220 |
Why?
|
| Reactive Oxygen Species | 5 | 2014 | 518 | 0.220 |
Why?
|
| Free Radicals | 4 | 2014 | 72 | 0.210 |
Why?
|
| Proteinuria | 4 | 2014 | 55 | 0.200 |
Why?
|
| Butyrates | 2 | 2019 | 34 | 0.200 |
Why?
|
| Glycerol | 3 | 2014 | 34 | 0.180 |
Why?
|
| Rats, Inbred SHR | 2 | 2014 | 30 | 0.180 |
Why?
|
| Polymers | 1 | 2023 | 151 | 0.180 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 273 | 0.170 |
Why?
|
| Xanthine Oxidase | 2 | 2013 | 9 | 0.170 |
Why?
|
| Morpholines | 1 | 2020 | 73 | 0.160 |
Why?
|
| Pyrimidines | 1 | 2020 | 130 | 0.150 |
Why?
|
| Male | 11 | 2014 | 22745 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 274 | 0.140 |
Why?
|
| Glutathione Transferase | 3 | 2007 | 90 | 0.140 |
Why?
|
| Neprilysin | 2 | 2010 | 8 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 2 | 2014 | 41 | 0.120 |
Why?
|
| Apoptosis | 2 | 2020 | 1541 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 1617 | 0.110 |
Why?
|
| Rats, Inbred WKY | 1 | 2014 | 16 | 0.110 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 3 | 2010 | 11 | 0.100 |
Why?
|
| Ligands | 1 | 2014 | 387 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 979 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1804 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1066 | 0.090 |
Why?
|
| Antioxidants | 2 | 2007 | 439 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 189 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 599 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1111 | 0.080 |
Why?
|
| Creatinine | 2 | 2010 | 102 | 0.080 |
Why?
|
| Liver | 1 | 2013 | 503 | 0.080 |
Why?
|
| Butyric Acid | 2 | 2007 | 19 | 0.080 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 10 | 0.080 |
Why?
|
| Glomerular Basement Membrane | 1 | 2010 | 9 | 0.080 |
Why?
|
| Sodium | 2 | 2007 | 101 | 0.080 |
Why?
|
| Cell Survival | 1 | 2013 | 934 | 0.080 |
Why?
|
| Indans | 2 | 2010 | 14 | 0.070 |
Why?
|
| Propionates | 2 | 2010 | 27 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 2 | 2006 | 134 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1554 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1420 | 0.070 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Renal Artery | 1 | 2007 | 7 | 0.070 |
Why?
|
| Thromboxane B2 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 26 | 0.070 |
Why?
|
| Nitrites | 1 | 2007 | 54 | 0.070 |
Why?
|
| Glutathione | 1 | 2007 | 170 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 710 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2010 | 548 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 31 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2005 | 55 | 0.060 |
Why?
|
| Vasodilation | 1 | 2005 | 63 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2005 | 100 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 100 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 181 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 141 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 692 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2005 | 884 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2023 | 82 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2023 | 72 | 0.050 |
Why?
|
| Pergolide | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2023 | 385 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 136 | 0.050 |
Why?
|
| Humans | 2 | 2020 | 42113 | 0.050 |
Why?
|
| Endothelin-1 | 3 | 2010 | 57 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 763 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 297 | 0.030 |
Why?
|
| Natriuresis | 2 | 2010 | 11 | 0.030 |
Why?
|
| Ascorbic Acid | 2 | 2006 | 74 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2006 | 452 | 0.020 |
Why?
|
| Desoxycorticosterone | 2 | 2003 | 9 | 0.020 |
Why?
|
| Nitrates | 1 | 2010 | 63 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 256 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 295 | 0.020 |
Why?
|
| Renal Circulation | 1 | 2006 | 20 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2006 | 76 | 0.020 |
Why?
|
| Nitriles | 1 | 2006 | 78 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 71 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 149 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 195 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 314 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 149 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 310 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 103 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 82 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 105 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 100 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 100 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 649 | 0.010 |
Why?
|
| Superoxides | 1 | 2002 | 57 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2002 | 34 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 266 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 462 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 534 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 594 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1076 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 973 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1265 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1845 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1246 | 0.010 |
Why?
|